GARZINO DEMO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.063
EU - Europa 225
AS - Asia 112
AF - Africa 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.061
CN - Cina 105
FI - Finlandia 71
SE - Svezia 56
IT - Italia 43
GB - Regno Unito 28
DE - Germania 18
HK - Hong Kong 4
IE - Irlanda 4
SC - Seychelles 3
CA - Canada 2
JP - Giappone 2
NL - Olanda 2
AU - Australia 1
EU - Europa 1
FR - Francia 1
IN - India 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 3.406
Salva come PNG Salva come JPEG
Città #
Fairfield 750
Woodbridge 315
Ashburn 269
Seattle 253
Houston 235
Cambridge 231
Wilmington 187
Ann Arbor 136
Chandler 132
San Diego 89
Medford 61
Princeton 61
Des Moines 40
Beijing 33
Nanjing 23
Padova 23
Boardman 19
Baltimore 18
Helsinki 18
Roxbury 14
Falls Church 13
Hebei 12
London 9
Ogden 8
Shenyang 8
Jiaxing 7
Las Vegas 5
Nanchang 5
Tianjin 5
Dublin 4
Norwalk 4
Central 3
Kilburn 3
Mahé 3
Chicago 2
Hounslow 2
Jinan 2
Lappeenranta 2
Milan 2
Phoenix 2
Redwood City 2
Rockville 2
Tokyo 2
Torino 2
Toronto 2
Berlin 1
Borås 1
Brescia 1
Buffalo 1
Chiswick 1
Fuzhou 1
Geislingen an der Steige 1
Kharkiv 1
Lanzhou 1
Mestre 1
Nuremberg 1
Orange 1
Porirua 1
Prescot 1
Surat 1
Sydney 1
Venice 1
Vicenza 1
Totale 3.036
Salva come PNG Salva come JPEG
Nome #
Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice 101
The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell 93
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17 84
Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ 84
Human Th17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection 80
B cell lymphoma in hiv transgenic mice 79
New targets for HIV drug discovery 77
Novel drugs targeting Toll-like receptors for antiviral therapy 76
Human immunodeficiency virus type 2 multiply spliced transcripts. 73
Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats 73
The θ-defensin retrocyclin 101 inhibits TLR4- and TLR2-dependent signaling and protects mice against influenza infection 72
Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element. 71
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. 69
Differential polarization of immune responses by co-administration of antigens with chemokines. 69
Chemokine receptors and chemokines in HIV infection. 69
C-C chemokine RANTES and HIV long terminal repeat-driven gene expression. 68
Infection of natural killer cells by human herpesvirus 6. 68
Response: Role of beta-Chemokines in Suppressing HIV Replication. 67
Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers 67
The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. 66
CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. 66
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. 65
CCR6 ligands inhibit HIV by inducing APOBEC3G 65
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. 63
Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients 63
Copy Number Variation of Defensin Genes and HIV Infection in Brazilian Children 62
The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. 62
Coping as a Multisystem Construct Associated With Pathways Mediating HIV-Relevant Immune Function and Disease Progression 62
Salivary histatin-5 and oral fungal colonisation in HIV+ individuals 62
Cloning trap for signal peptide sequences. 61
HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape 60
Human beta defensin 2 selectively inhibits HIV-1 in highly permissive CCR6+CD4+ T cells 60
Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization. 59
Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection. 58
Fresh faces and new approaches at Pathogens and Disease 58
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status 57
The role of chemokines in human immunodeficiency virus infection. 57
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of   chemokines and RNases 56
Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4. 56
The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. 54
Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. 54
HIV receptors on lymphocytes. 53
Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression 48
The retrocyclin analogue RC-101 inhibits Ebola virus infection in vitro. 45
Chemokines and defensins as HIV suppressive factors: an evolving story. 42
Peptide stapling with the retention of double native side-chains 42
HIV-1 decreases the levels of neurotrophins in human lymphocytes 41
Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. 38
Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages 38
Mechanism through which retrocyclin targets flavivirus multiplication 35
LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain 35
Cloning of a novel chemoattractant receptor activated by leukotriene B4 and used by human immunodeficiency virus type 1 to infect CD4-positive immune cells. A therapeutic connection to asthma? 32
Effects of 17-beta-estradiol on the ontogenesis of striatal dopaminergic receptors. 31
Beta-chemokines and protection from HIV type 1 disease. 29
Some recent results on HIV pathogenesis with implications for therapy and vaccines. 28
HIV infection and pathogenesis: what about chemokines? 24
HIV-Associated Interactions Between Oral Microbiota and Mucosal Immune Cells: Knowledge Gaps and Future Directions 24
Editorial: Novel Insights Into a Functional HIV Cure 24
Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. 22
Inhibition of HIV-1 infection by the beta-chemokine MDC. 21
Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis 16
Decreased MIP-3α production from antigen-activated PBMCs in symptomatic HIV-infected subjects 13
Long COVID: a review and proposed visualization of the complexity of long COVID 7
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies 2
Biological mechanisms underpinning the development of long COVID 1
Totale 3.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.145
article - articoli 14.014
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019289 0 0 0 0 0 0 0 0 0 0 165 124
2019/2020807 123 30 15 59 101 68 87 96 97 67 48 16
2020/2021691 22 27 16 32 49 21 2 36 86 118 57 225
2021/2022875 19 63 109 155 22 37 81 116 18 26 63 166
2022/2023348 104 1 1 30 68 54 1 25 41 3 8 12
2023/2024156 6 35 28 14 8 17 13 12 19 2 2 0
Totale 3.457